Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Elsemieke Passchier

2PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 03, 2024
Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.

Chilam Chan, J H Marco Jansen, Ilona S T Hendriks

|Feb 12, 2024
MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C.

Celia Segui-Perez, Daphne A C Stapels, Ziliang Ma

Pageof 1

Frequent Collaborators

1 joint publications

Chilam Chan

1 joint publications

J H Marco Jansen

1 joint publications

Ilona S T Hendriks

1 joint publications

Ida C van der Peet

1 joint publications

Meggy E L Verdonschot

1 joint publications

Maria Tsioumpekou

1 joint publications

Maaike Nederend

1 joint publications

Sharon A Klomp

1 joint publications

Thomas Valerius

1 joint publications

Matthias Peipp

Frequent Collaborators

1 joint publications

Chilam Chan

1 joint publications

J H Marco Jansen

1 joint publications

Ilona S T Hendriks

1 joint publications

Ida C van der Peet

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.5K
<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability
10:22

<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability

Published on : Oct 19, 2018

25.5K
See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.5K
<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability
10:22

<em>In Vitro</em> and <em>In Vivo </em>Approaches to Determine Intestinal Epithelial Cell Permeability

Published on : Oct 19, 2018

25.5K
See more related videos